EU: Pfizer Warns Doctors About Blood Clot Risk With Xeljanz

 
• By Neena Brizmohun

Now that the European Medicines Agency has finalized its formal safety review procedure into Xeljanz, Pfizer is telling health care professionals what precautions they must take when prescribing the drug.

Blood_Clot
Xeljanz can increase the risk of blood clots in high-risk patients • Source: Shutterstock

More from Europe

More from Geography